LCTX: Lineage Cell Therapeutics Inc

LCTX新闻

• 01:50 Lineage Cell Therapeutics, Inc. (LCTX) Q1 2026 Earnings Call Transcript
• 21:10 Lineage Cell (LCTX) Reports Q1 Loss, Lags Revenue Estimates
• 21:15 Halozyme Therapeutics (HALO) Surpasses Q1 Earnings and Revenue Estimates
• 23:36 Lineage Cell Therapeutics, Inc. (LCTX) Presents at FFB Retinal Therapeutics Innovation Summit - Slideshow (NYSE:LCTX) 2026-05-07
• 21:55 Guardant Health (GH) Reports Q1 Loss, Beats Revenue Estimates
• 13:13 Lineage Cell Therapeutics提交招股说明书补充文件 拟发行至多6000万美元股票
• 13:12 Lineage Cell Therapeutics files prospectus supplement for up to $60 million share offering
• 14:48 H.C. Wainwright重申Lineage Cell股票买入评级,目标价9美元
• 14:46 H.C. Wainwright reiterates Buy on Lineage Cell stock, $9 target
• 02:45 Lineage Cell Therapeutics, Inc. (LCTX) Q4 2025 Earnings Call Transcript
• 00:24 Lineage Cell TherapeuticsQ1每股收益及营收超出预期
• 00:24 Lineage Cell Therapeutics earnings beat by $0.05, revenue topped estimates
• 22:30 Lineage Cell (LCTX) Reports Break-Even Earnings for Q4
• 14:15 Prime Medicine, Inc. (PRME) Reports Q4 Loss, Misses Revenue Estimates
• 22:30 Pacira (PCRX) Lags Q4 Earnings and Revenue Estimates
• 22:06 Beyond Meat任命Tony Kalajian为首席会计官
• 22:05 Beyond Meat appoints Tony Kalajian as chief accounting officer
• 13:14 Lineage Cell Therapeutics highlights 2025 achievements in cell therapy
• 08:00 Snowflake, Symbotic And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - ADC Therapeutics (NYSE:ADCT), Capricor Therapeutics (NASDAQ:CAPR)
• 21:23 Lineage Cell Therapeutics撤回CIRM资助申请，计划重新提交
• 21:22 Lineage Cell Therapeutics withdraws CIRM grant application, plans resubmission
• 09:10 Lineage Cell Therapeutics Stock: OpRegen Makes It A Viable Speculative Buy (NYSE:LCTX)
• 14:33 Lineage Cell Therapeutics向Janus Henderson出售1200万股股票，融资2100万美元
• 14:33 Lineage Cell Therapeutics sells 12 million shares to Janus Henderson for $21 million